| Online-Ressource |
Verfasst von: | Schmitt, Stefan [VerfasserIn]  |
| Mailänder, Volker [VerfasserIn]  |
| Egerer, Gerlinde [VerfasserIn]  |
| Leo, Albrecht [VerfasserIn]  |
| Becker, Sven [VerfasserIn]  |
| Reinhardt, P. [VerfasserIn]  |
| Wiesneth, M. [VerfasserIn]  |
| Schrezenmeier, H. [VerfasserIn]  |
| Ho, Anthony Dick [VerfasserIn]  |
| Goldschmidt, Hartmut [VerfasserIn]  |
| Möhler, Thomas [VerfasserIn]  |
Titel: | Successful autologous peripheral blood stem cell transplantation in a Jehovah’s Witness with multiple myeloma |
Titelzusatz: | review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood products |
Verf.angabe: | S. Schmitt, V. Mailaender, G. Egerer, A. Leo, S. Becker, P. Reinhardt, M. Wiesneth, H. Schrezenmeier, A.D. Ho, H. Goldschmidt, T.M. Moehler |
E-Jahr: | 2008 |
Jahr: | 4 March 2008 |
Umfang: | 9 S. |
Illustrationen: | Diagramme |
Fussnoten: | Gesehen am 13.10.2021 |
Titel Quelle: | Enthalten in: International journal of hematology |
Ort Quelle: | Tokyo [u.a.] : Springer, 1995 |
Jahr Quelle: | 2008 |
Band/Heft Quelle: | 87(2008), 3 vom: März, Seite 289-297 |
ISSN Quelle: | 1865-3774 |
Abstract: | We present a case report of a successful high-dose melphalan therapy and autologous stem cell transplantation without the use of allogeneic blood product support in a 70-year-old patient suffering from multiple myeloma. Based on the experience in this case and thorough evaluation of the literature, we consider pre-transplant Hb level of 11-12 g/dl, platelet count higher than 70/nl, good WHO performance status of two and lower and informed consent as important eligibility criteria. During cytopenia recommended supportive measures include growth factor support with erythropoietin and G-CSF, p.o. iron treatment as well as prophylactic use of anti-fibrinloytic agents. Furthermore we discuss additional options that might be considered depending on the individual factors as e.g. pre-transplant collection and cryoconservation of autologous platelet concentrates. Moreover, an analysis of socio-economic issues regarding this procedure is presented. We conclude that allogeneic blood product free transplantation is a feasible procedure that can be offered to the patients belonging to distinct religious groups refusing allogeneic blood products as Jehova´s Witnesses and patients presenting other contraindications for transfusions. |
DOI: | doi:10.1007/s12185-008-0055-x |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1007/s12185-008-0055-x |
| DOI: https://doi.org/10.1007/s12185-008-0055-x |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 177356028X |
Verknüpfungen: | → Zeitschrift |
Successful autologous peripheral blood stem cell transplantation in a Jehovah’s Witness with multiple myeloma / Schmitt, Stefan [VerfasserIn]; 4 March 2008 (Online-Ressource)